Cargando…

A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014

INTRODUCTION: Most research on hepatitis B virus (HBV) infection in the United States is limited to Asian populations, despite an equally high prevalence among African immigrants. The purpose of this study was to determine testing and detection rates of HBV infection among African-born people residi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrasekar, Edwin, Song, Sharon, Johnson, Matthew, Harris, Aaron M., Kaufman, Gary I., Freedman, David, Quinn, Michael T., Kim, Karen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008862/
https://www.ncbi.nlm.nih.gov/pubmed/27584874
http://dx.doi.org/10.5888/pcd13.160162
_version_ 1782451453621698560
author Chandrasekar, Edwin
Song, Sharon
Johnson, Matthew
Harris, Aaron M.
Kaufman, Gary I.
Freedman, David
Quinn, Michael T.
Kim, Karen E.
author_facet Chandrasekar, Edwin
Song, Sharon
Johnson, Matthew
Harris, Aaron M.
Kaufman, Gary I.
Freedman, David
Quinn, Michael T.
Kim, Karen E.
author_sort Chandrasekar, Edwin
collection PubMed
description INTRODUCTION: Most research on hepatitis B virus (HBV) infection in the United States is limited to Asian populations, despite an equally high prevalence among African immigrants. The purpose of this study was to determine testing and detection rates of HBV infection among African-born people residing in the Chicago metropolitan area. METHODS: A hepatitis education and prevention program was developed in collaboration with academic, clinical, and community partners for immigrant and refugee populations at risk for HBV infection. Community health workers implemented chain referral sampling, a novel strategy for recruiting hard-to-reach participants, targeting African-born participants. Participants were tested in both clinical and nonclinical settings. To assess infection status, blood samples were obtained for hepatitis B surface antigen (HBsAg), core antibody, and surface antibody testing. Demographic information was collected on age, sex, health insurance status, country of origin, and years residing in the United States. Participants were notified of testing results, and HBsAg-positive participants were referred for follow-up medical care. RESULTS: Of 1,000 African-born people who received education, 445 (45%) agreed to participate in HBV screening. There were 386 (87%) participants tested in clinical and 59 (13%) tested in nonclinical sites. Compared with participants who were tested in clinical settings, participants tested in nonclinical settings were older, were less likely to have health insurance, and had lived in the United States longer (P < .005 for each). Of these, most were from the Democratic Republic of the Congo (14%), Nigeria (13%), Ghana (11%), Somalia (11%), or Ethiopia (10%). There were 35 (8%) HBsAg-positive people, 37% had evidence of past infection, and 29% were immune. CONCLUSIONS: Chain referral sampling identified many at-risk African-born people with chronic HBV infection. The large proportion of HBsAg-positive people in this sample reinforces the need for health promotion programs that are culturally appropriate and community-driven.
format Online
Article
Text
id pubmed-5008862
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-50088622016-09-14 A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014 Chandrasekar, Edwin Song, Sharon Johnson, Matthew Harris, Aaron M. Kaufman, Gary I. Freedman, David Quinn, Michael T. Kim, Karen E. Prev Chronic Dis Original Research INTRODUCTION: Most research on hepatitis B virus (HBV) infection in the United States is limited to Asian populations, despite an equally high prevalence among African immigrants. The purpose of this study was to determine testing and detection rates of HBV infection among African-born people residing in the Chicago metropolitan area. METHODS: A hepatitis education and prevention program was developed in collaboration with academic, clinical, and community partners for immigrant and refugee populations at risk for HBV infection. Community health workers implemented chain referral sampling, a novel strategy for recruiting hard-to-reach participants, targeting African-born participants. Participants were tested in both clinical and nonclinical settings. To assess infection status, blood samples were obtained for hepatitis B surface antigen (HBsAg), core antibody, and surface antibody testing. Demographic information was collected on age, sex, health insurance status, country of origin, and years residing in the United States. Participants were notified of testing results, and HBsAg-positive participants were referred for follow-up medical care. RESULTS: Of 1,000 African-born people who received education, 445 (45%) agreed to participate in HBV screening. There were 386 (87%) participants tested in clinical and 59 (13%) tested in nonclinical sites. Compared with participants who were tested in clinical settings, participants tested in nonclinical settings were older, were less likely to have health insurance, and had lived in the United States longer (P < .005 for each). Of these, most were from the Democratic Republic of the Congo (14%), Nigeria (13%), Ghana (11%), Somalia (11%), or Ethiopia (10%). There were 35 (8%) HBsAg-positive people, 37% had evidence of past infection, and 29% were immune. CONCLUSIONS: Chain referral sampling identified many at-risk African-born people with chronic HBV infection. The large proportion of HBsAg-positive people in this sample reinforces the need for health promotion programs that are culturally appropriate and community-driven. Centers for Disease Control and Prevention 2016-09-01 /pmc/articles/PMC5008862/ /pubmed/27584874 http://dx.doi.org/10.5888/pcd13.160162 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
Chandrasekar, Edwin
Song, Sharon
Johnson, Matthew
Harris, Aaron M.
Kaufman, Gary I.
Freedman, David
Quinn, Michael T.
Kim, Karen E.
A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014
title A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014
title_full A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014
title_fullStr A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014
title_full_unstemmed A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014
title_short A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012–2014
title_sort novel strategy to increase identification of african-born people with chronic hepatitis b virus infection in the chicago metropolitan area, 2012–2014
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008862/
https://www.ncbi.nlm.nih.gov/pubmed/27584874
http://dx.doi.org/10.5888/pcd13.160162
work_keys_str_mv AT chandrasekaredwin anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT songsharon anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT johnsonmatthew anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT harrisaaronm anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT kaufmangaryi anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT freedmandavid anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT quinnmichaelt anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT kimkarene anovelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT chandrasekaredwin novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT songsharon novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT johnsonmatthew novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT harrisaaronm novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT kaufmangaryi novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT freedmandavid novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT quinnmichaelt novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014
AT kimkarene novelstrategytoincreaseidentificationofafricanbornpeoplewithchronichepatitisbvirusinfectioninthechicagometropolitanarea20122014